SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001159036-22-000050
Filing Date
2022-08-09
Accepted
2022-08-09 16:12:00
Documents
85
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q halo-20220630.htm   iXBRL 10-Q 2038048
2 EX-31.1 ex31110qq22022.htm EX-31.1 13057
3 EX-31.2 ex31210qq22022.htm EX-31.2 12997
4 EX-32 ex3210qq22022.htm EX-32 13911
10 halo-20220630_g1.jpg GRAPHIC 115451
11 halo-20220630_g2.jpg GRAPHIC 101625
  Complete submission text file 0001159036-22-000050.txt   9893012

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT halo-20220630.xsd EX-101.SCH 53092
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT halo-20220630_cal.xml EX-101.CAL 97870
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT halo-20220630_def.xml EX-101.DEF 301333
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT halo-20220630_lab.xml EX-101.LAB 684786
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT halo-20220630_pre.xml EX-101.PRE 475369
79 EXTRACTED XBRL INSTANCE DOCUMENT halo-20220630_htm.xml XML 1754617
Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345
Business Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Filer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32335 | Film No.: 221148423
SIC: 2836 Biological Products, (No Diagnostic Substances)